EPIS B — Episurf Medical AB Share News
0.000.00%
Last trade - 00:00- SEK438.03m
- SEK700.73m
- SEK13.50m
Brief: New Patent Approval In Hong Kong For Episurf Medical
Brief: Episurf Medical Gets New Patent Approval In Hong Kong
Brief: Episurf Q2 Loss Widens To SEK 19.4 Mln
Brief: Episurf Medical: Episealer Results To Be Presented At Congress
Brief: Episurf Medical Q1 Loss For Period Narrows To SEK 16.4 Mln
Brief: Episurf Medical Says Episealer® Patellofemoral System Under Substantive Review At The US FDA
Brief: Episurf Medical Gets New Patent Approval In Hong Kong
Brief: New European Patent Approval For Episurf Medical
Brief: Episurf Medical Receives First Indian Patent Approval
Brief: Episurf Medical Gets New Chinese Patent Approval
Brief: New US Patent Approval For Episurf Medical
Brief: Episurf Medical Enters Commercial Agency Agreement With Ideal Med
Brief: Episurf Medical Receives Reimbursement Coverage For Episealer Talus In Belgium
Brief: Episurf Medical's Implants Receive National Regulatory Approval In Hong Kong
Brief: Episurf Medical Q4 Loss Widens To SEK 18.9 Mln
Brief: New European Patent Approval For Episurf Medical
Brief: Episurf's Implants Approved For Sale In Malaysia
Brief: Episurf Medical: New European Patent Approval
Brief: Episurf Medical Submits 510(K) Application For Episealer® Patellofemoral System